Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03172286
Other study ID # 2016-43
Secondary ID 2016-A01499-42
Status Recruiting
Phase N/A
First received March 30, 2017
Last updated May 29, 2017
Start date April 10, 2017
Est. completion date December 31, 2018

Study information

Verified date March 2017
Source Assistance Publique Hopitaux De Marseille
Contact Florence Bretelle, MD
Phone +33491964525
Email frlorence.bretelle@ap-hm.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A study in the postpartum period reveals that among women who delivered vaginally and having perineal lesions, between 95 and 100% of them suffer from perineal pain (episiotomy, tears from 1st to 4th degree) to 24 hours of vaginal delivery; and between 60 and 91% 7 days after delivery.

Severe pain that is not taken into account can become chronic pain. It has physical and psychological consequences. It is therefore essential to prevent these risks in young mothers.

The main objective of this study is to assess the efficacy of radiofrequency treatment on perineal pain postpartum, after a vaginal delivery, instrumented or not, in patients with perineal lesions.

A double-blind randomized prospective single-center study will be conducted on patients delivering at Marseille's north hospital.

Women who gave birth to the North hospital site, with perineal lesions (tears, episiotomy) will be invited to enroll in the study.

Patients will be then randomized into two groups, one with radiofrequency treatment, the other without treatment with radiofrequency.

The duration of inclusion is provided over 6 months. Each topic will be followed over a period of 1 month. The total study duration is 7 months.

The expected results are a significant reduction in pain scores during the first days postpartum in women with perineal alteration caused by a vaginal delivery instrumented or not. Also an improvement in the quality of life of patients during the first days.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date December 31, 2018
Est. primary completion date April 1, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who naturaly delivered with ou without instruments such as Suction cup, spatulas, forceps

- Patients presenting perineal lesions

Exclusion Criteria:

- Patients who delivered through cesarean section

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Radiofrequencer
Patients will be treated with a radiofrenquencer switched on or off depending on the attributed group after randomization

Locations

Country Name City State
France Assistance Publique Hôpitaux de Masreille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain score using analogical pain scale Pain score will be assessed before and after the radiofrequencing cession 30 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05468658 - The Effect of Feng Shui Delivery Room Design on Maternal and Infant Health N/A